(205) found that Dectin-1 expressed on immune cells can also sense the N-glycan structure of tumor cells and thus activate anti-cancer immune responses, which indicates that the fungal ligand may not be the only stimulator for CLR activation and that TAMPs may also be ligands at CLRs and regulate their expression or activation. The gene discussed is LARS1; the disease is cancer.